secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2024-01-24T23:59:59+00:00
Accession:  0001104659-24-006042
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet Biosciences reports preliminary cash of $94.9M as of Dec 31, 2023
-------------------------------------------------------------------------

- Cash, cash equivalents and short-term investments estimated at ~$94.9M.
- Amount is unaudited, prepared by management and subject to completion of closing procedures.
- Actual year-end 2023 results may differ; will be included in Form 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465924006042/0001104659-24-006042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465924006042/tm2333216d9_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-006042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer